UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, ~~D.C.~~DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

~~Pursuant~~TO ~~to Section~~ SECTION 13 OR 15(dD) ofOF ~~the~~THE ~~Securities Exchange Act of 1934~~

~~Date~~SECURITIES ofEXCHANGE ~~Report~~ACT ~~(Date~~OF of1934 ~~earliest event reported): July 28, 2006~~

~~TELZUIT~~Date ~~MEDICAL~~of ~~TECHNOLOGIES~~report (Date of earliest event reported) June 1, ~~INC.~~ 2007

~~(Exact~~Telzuit ~~name~~Medical ofTechnologies, ~~Registrant~~Inc. ~~as specified in its charter)~~

~~Commission~~(Exact ~~file~~Name ~~number~~of ~~001-15034~~ Registrant as Specified in Its Charter)

Florida		01-0656115
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer identification no.)

Florida

5422 Carrier Drive, Suite 306 Orlando, Florida		32819
(Address of principal executive offices)		(Zip code)

(State or Other Jurisdiction of Incorporation)


001-15034		01-0656115
(Commission File Number)		(IRS Employer Identification No.)


5422 Carrier Drive, Suite 306, Orlando, Florida		32819
(Address of Principal Executive Offices)		(Zip Code)

(407) 354-1222

(Registrant’s ~~telephone~~Telephone ~~number~~Number, ~~including~~Including ~~area~~Area ~~code~~Code)

~~(Former~~N/A ~~name or former address, if changed since last report)~~

~~Check~~(Former ~~the~~Name ~~appropriate~~or ~~box~~Former ~~below~~Address, if ~~the~~Changed ~~Form~~Since ~~8-K~~Last ~~filing~~Report) ~~is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:~~

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre -commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 45.0103 ~~Changes~~Amendments into ~~Registrant’s~~Articles ~~Certifying~~of ~~Accountant~~Incorporation or Bylaws; Change in Fiscal Year.

~~Effective~~On ~~July 28~~June 1, ~~2006~~2007, Telzuit Medical Technologies, Inc. (the “Company”) ~~engaged~~amended ~~Cross,~~its ~~Fernandez~~Articles &of ~~Riley,~~Incorporation ~~LLP~~to asincrease ~~its~~the ~~new~~number ~~independent~~of ~~registered~~authorized ~~public~~shares ~~accountant~~of ~~to audit~~ the Company’s ~~financial~~Common ~~statements~~Stock, ~~for~~$.001 ~~the~~par value ~~year~~per ~~ended~~share, ~~June~~from 30100,000,000 ~~2006~~shares to 125,000,000 shares.

~~During~~A ~~the~~copy ~~two most recent fiscal years and the interim period between June 30, 2006 and July 6, 2006 (the date~~ of ~~dismissal of~~ the ~~Company’s~~Articles ~~prior independent registered public accounting firm), neither the Company (nor anyone on its behalf) consulted Cross, Fernandez & Riley, LLP regarding (i) the application~~ of ~~accounting~~Amendment ~~principles~~ to ~~a specified transaction, either completed or proposed, or~~ the ~~type of audit opinion that might be rendered on the~~ Company’s ~~financial~~Articles ~~statements, and neither a written nor oral report was provided to the Company in which a conclusion reached by the new~~of ~~accountant~~Incorporation ~~was~~is anattached ~~important factor considered by the Company in reaching a decision~~ as toExhibit ~~the~~3.1 ~~accounting, auditing or financial reporting issue; or (ii) any matter that was subject~~ to ~~any~~this ~~disagreement~~Current orReport ~~reportable~~and ~~event~~is ~~under~~incorporated ~~Item~~by ~~304(a)(1)~~reference ~~of Regulation S-B~~herein.

~~SIGNATURE~~Item 9.01 Financial Statements and Exhibits.

(d) Exhibits


Exhibit No.		Description
3.1		Articles of Amendment to Articles of Incorporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Telzuit Medical Technologies, Inc.
June 6, 2007	TELZUIT MEDICAL TECHNOLOGIES, INC.
		(Registrant)
	/s/ Warren D. Stowell
Date: July 31, 2006		By:	/s/ Warren Stowell
	Name:	Warren D. Stowell
			Warren D. Stowell President and Chief Executive Officer
	Title:	President

EXHIBIT INDEX


Exhibit Number		Description
3.1		Articles of Amendment to Articles of Incorporation.

Filing Compare · Telzuit Medical Technologies, Inc.